Search

Your search keyword '"Hammond, Sue"' showing total 299 results

Search Constraints

Start Over You searched for: Author "Hammond, Sue" Remove constraint Author: "Hammond, Sue"
299 results on '"Hammond, Sue"'

Search Results

2. Non-fiction

3. Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors.

7. Data from Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors

8. Supplementary Table 1 from Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors

9. Supplementary Figure 1 from Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors

10. Supplementary Files from Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors

11. Data from FANCD2 Is a Potential Therapeutic Target and Biomarker in Alveolar Rhabdomyosarcoma Harboring the PAX3–FOXO1 Fusion Gene

12. Supplementary Legend from Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors

13. Supplementary Figure 3 from Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors

14. Data from Chemotherapy and Thyroid Cancer Risk: A Report from the Childhood Cancer Survivor Study

15. Supplementary Figure 4 from Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors

16. Supplementary Figure 1 from FANCD2 Is a Potential Therapeutic Target and Biomarker in Alveolar Rhabdomyosarcoma Harboring the PAX3–FOXO1 Fusion Gene

17. Supplementary Figure 3 from FANCD2 Is a Potential Therapeutic Target and Biomarker in Alveolar Rhabdomyosarcoma Harboring the PAX3–FOXO1 Fusion Gene

18. Supplementary Figure Legends from FANCD2 Is a Potential Therapeutic Target and Biomarker in Alveolar Rhabdomyosarcoma Harboring the PAX3–FOXO1 Fusion Gene

19. Supplementary Figure 5 from Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors

20. Supplementary Figure 2 from Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors

21. Supplementary Figure 2 from FANCD2 Is a Potential Therapeutic Target and Biomarker in Alveolar Rhabdomyosarcoma Harboring the PAX3–FOXO1 Fusion Gene

22. Supplementary Tables 1-2 from Chemotherapy and Thyroid Cancer Risk: A Report from the Childhood Cancer Survivor Study

23. Supplementary Tables 1 - 4 from FANCD2 Is a Potential Therapeutic Target and Biomarker in Alveolar Rhabdomyosarcoma Harboring the PAX3–FOXO1 Fusion Gene

24. Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects

25. Towards Mentoring as Feminist Praxis in Early Childhood Education and Care in England

26. Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer

29. Wild Woods or Urban Jungle: Playing It Safe or Freedom to Roam

32. Risk of Second Primary Thyroid Cancer after Radiotherapy for a Childhood Cancer in a Large Cohort Study: An Update from the Childhood Cancer Survivor Study

33. Healthy Later Living in a time of COVID.:CASP Policy Labs:Executive Summary

37. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study

41. Secondary Gastrointestinal Cancer in Childhood Cancer Survivors: A Cohort Study

Catalog

Books, media, physical & digital resources